Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis

Stéphane Ederhy, Joe Elie Salem, Laurent Dercle, Abrar Saqif Hasan, Marion Chauvet-Droit, Pascal Nhan, Samy Ammari, Bruno Pinna, Alban Redheuil, Samia Boussouar, Stephane Champiat, Laurie Soulat-Dufour, Ariel Cohen

    Résultats de recherche: Contribution à un journalArticle 'review'Revue par des pairs

    10 Citations (Scopus)

    Résumé

    Immune checkpoint inhibitors (ICI) have constituted a paradigm shift in the management of patients with cancer. Their administration is associated with a new spectrum of immune-related toxicities that can affect any organ. In patients treated with ICI, cardiovascular toxicities, particularly myocarditis, occur with a low incidence (<1%) but with a high fatality rate (30−50%). ICI-related myocarditis has been attributed to an immune infiltration, comprising of T-cells that are positive for CD3+, CD4+, CD8+, and macrophages that are positive for CD68. The diagnosis remains challenging and is made based on clinical syndrome, an electrocardiogram (ECG), biomarker data, and imaging criteria. In most clinical scenarios, endomyocardial biopsy plays a pivotal role in diagnosis, while cardiac magnetic resonance imaging (cMRI) has limitations that should be acknowledged. In this review, we discuss the role of medical imaging in optimizing the management of ICI related myocarditis, including diagnosis, prognostication, and treatment decisions.

    langue originaleAnglais
    Numéro d'article640985
    journalFrontiers in Oncology
    Volume11
    Les DOIs
    étatPublié - 13 mai 2021

    Contient cette citation